NCT06617000 A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related Status RECRUITING Phase PHASE1
NCT06609876 Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC Status RECRUITING Phase NA
NCT06607120 Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies Status RECRUITING Phase N/A
NCT06602011 Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) Status RECRUITING Phase N/A
NCT06592612 Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT06590246 A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC) Status RECRUITING Phase PHASE1/PHASE2
NCT06582017 Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06581315 Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06577272 Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients Status RECRUITING Phase N/A
NCT06558227 Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06553885 Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC Status RECRUITING Phase PHASE2
NCT06551272 Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT06550739 Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients Status COMPLETED Phase N/A
NCT06549829 The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06546280 A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation Status NOT_YET_RECRUITING Phase PHASE2
NCT06544083 Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood Status RECRUITING Phase N/A
NCT06544005 Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis Status COMPLETED Phase N/A
NCT06543030 Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase N/A
NCT06542796 Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma Status RECRUITING Phase NA